QRxPharma and Aesica Formulation Development, a subsidiary of Aesica Pharmaceuticals, will collaborate on the world-wide promotion of QRxPharma’s proprietary Stealth Beadlets abuse deterrence technology. Under the non-exclusive collaboration agreement, Aesica will promote QRxPharma’s Stealth Beadlets technology for inclusion in clients’ existing formulations of controlled drugs. Aesica will enter into fee-for-service contracts with such third parties for the development of the...